Compare ARK Genomic Revolution ETF (ARKG) vs Petróleo Brasileiro SA (PBR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Petróleo Brasileiro SA — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Petróleo Brasileiro SA trades at $17.47 (market cap $105.14B). The key difference: Petróleo Brasileiro SA pays a 10.18% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Petróleo Brasileiro SA nearer its low. Which is the better fit depends on your goals.
| ARKG | PBR | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $22.03 |
52-Week Low | $23.09 | $11.54 |
Market Cap | — | $105.14B |
Enterprise Value | — | $167.68B |
Dividend Yield | — | 10.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Petrobras (PBR) trades at $17.32, up 1.7% with bullish technical signals and strong fundamentals. The stock shows attractive valuation metrics with P/E of 5.52 and ROE of 24.94%, supported by robust cash flow generation of $197.5B in 2025. Recent developments include strategic partnerships with Pemex and renewable energy investments, while maintaining consistent dividend payments.
PBR presents compelling value with significant upside to the $23.90 consensus target, though faces risks from commodity volatility and recent earnings miss. The company's production growth and cost discipline support long-term investment case, but investors should monitor execution on new projects and oil price sensitivity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Petróleo Brasileiro SA
Petróleo Brasileiro S.A., commonly known as Petrobras, is a state-controlled Brazilian multinational corporation in the oil and gas industry. The company is one of the world's largest producers of oil and gas, primarily operating in exploration, production, refining, and power generation. Petrobras is particularly known for its deep-sea and ultra-deep-sea exploration and production activities in the vast pre-salt offshore reserves, which are a major component of Brazil's economy.
Read more on PBR →
